Amgen invests $650 million on expansion of US manufacturing network
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
BIL also holds an option to increase its equity stake by an additional 15%
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Merck opens first climate-neutral manufacturing facility in Ireland
The lab will facilitate the development of herbal and natural-based solutions
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Subscribe To Our Newsletter & Stay Updated